As part of the ProxiUS program, funded by the Federal Ministry of Research, Technology and Space, PROXIDRUGS speaker Ivan Đikić visited the Molecular Therapeutics Initiative (MTI) at the University of California, Berkeley for scientific exchange and discussion. The visit highlighted the strong synergy between PROXIDRUGS and MTI. Bringing together complementary expertise and new perspectives, the exchange created valuable opportunities for knowledge transfer, education, and fu

As part of a political breakfast organized by the House of Pharma & Healthcare, representatives from academia, industry, and politics gathered for an exchange at the Department of Pharmacy of Goethe University Frankfurt. A special highlight of the program was an insight into the research activities of PROXIDRUGS. Project lead Maike Windbergs guided State Secretary Dr. Optendrenk through her laboratories and presented innovative approaches in drug delivery and human in vitro m

On February 11th, Kerstin Koch, project lead of the PROXIDRUGS project InnoDATA, joined a panel discussion at the closing event of the series “Die Farben der Biotechnologie” hosted by Technologieland Hessen. The event brought together experts from across the biotech landscape to discuss how innovation ecosystems and clusters can act as accelerators for scientific and technological progress. As part of the panel, PROXIDRUGS contributed the cluster perspective to the dialogue,

Scientists from Ivan Đikić lab at Goethe University Frankfurt and Radosław Nowak lab at the University of Bonn, within PROXIDRUGs network, invented ProxiCapture – an innovative affinity-proteomics platform that enables the systematic analysis of degrader-induced protein interactions directly in native cell and tissue samples. Molecular glue degraders are an emerging class of small molecules that can redirect cellular protein disposal systems to eliminate disease-relevant prot

On February 6, 2026, representatives from academia, clinic, industry, and politics met to an exchange meeting of the House of Pharma & Healthcare. The focus of the meeting was a structured overview of the activities of the House of Pharma & Healthcare as a platform for interdisciplinary exchange and knowledge transfer between universities, industry, and the public sector. The importance of Frankfurt as a hub for pharmaceutical research, education, and translation was particul